Skip to main content

Marrone Bio Innovations, Inc. (MBII)

NASDAQ: MBII · IEX Real-Time Price · USD
0.696
-0.029 (-3.93%)
At close: Nov 26, 2021 1:00 PM
0.692
-0.004 (-0.575%)
After-hours:Nov 26, 2021 3:58 PM EST
Market Cap123.30M
Revenue (ttm)41.21M
Net Income (ttm)-15.45M
Shares Out177.15M
EPS (ttm)-0.09
PE Ration/a
Forward PE104.17
Dividendn/a
Ex-Dividend Daten/a
Volume540,780
Open0.818
Previous Close0.725
Day's Range0.680 - 0.737
52-Week Range0.770 - 2.900
Beta0.30
AnalystsBuy
Price Target2.44 (+250.6%)
Earnings DateNov 10, 2021

About MBII

Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Emergen, Foramin, Foramin ST, Pacesetter, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, elim...

IndustryChemicals
IPO DateAug 2, 2013
CEOPamela Marrone
Employees145
Stock ExchangeNASDAQ
Ticker SymbolMBII
Full Company Profile

Financial Performance

In 2020, MBII's revenue was $38.37 million, an increase of 30.64% compared to the previous year's $29.37 million. Losses were -$20.17 million, -45.75% less than in 2019.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for MBII stock is "Buy." The 12-month stock price forecast is 2.44, which is an increase of 250.57% from the latest price.

Price Target
$2.44
(250.57% upside)
Analyst Consensus: Buy

News

7 Hot Penny Stocks to Buy for December That Are Positioned to Pop

These penny stocks remain positioned to run upwards in the near term. Purchasing shares in December could quickly lead to profits.

2 days ago - InvestorPlace

Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide

DAVIS, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions published today their...

1 week ago - GlobeNewsWire

7 Penny Stocks to Book Profits on Before 2022

Penny stocks can turn a quick profit. These 7 picks are designed to do so before the end of this year and cover multiple sectors.

Other symbols:ARECIMRALODEOBSVSNCR
1 week ago - InvestorPlace

Marrone Bio (MBII) Q3 Earnings In Line, Revenues Lag Estimates

Marrone Bio's (MBII) third-quarter revenues were driven by strategic focus on global expansion in the major row crops.

1 week ago - Zacks Investment Research

Marrone Bio Innovations, Inc. (MBII) Reports Q3 Loss, Misses Revenue Estimates

Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of 0.00% and -8.61%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for th...

2 weeks ago - Zacks Investment Research

Marrone Bio Innovations, Inc. Reports Third-Quarter 2021 Financial Results

DAVIS, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial...

2 weeks ago - GlobeNewsWire

Marrone Bio Innovations Receives Nasdaq Notice Regarding Failure to Satisfy a Continued Listing Rule

DAVIS, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (Nasdaq: MBII) today announced that it has received a letter from the Listing Qualifications Department of the Nasdaq Capit...

2 weeks ago - GlobeNewsWire

Will Marrone Bio Innovations, Inc. (MBII) Report Negative Earnings Next Week? What You Should Know

Marrone Bio Innovations, Inc. (MBII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago - Zacks Investment Research

Marrone Bio Submits Regulatory Packages for Nematicides/Insecticides in United States and Brazil

Peak potential revenue for both products is estimated in excess of $100 million Peak potential revenue for both products is estimated in excess of $100 million

3 weeks ago - GlobeNewsWire

Marrone Bio (MBII) Herbicides Enter Late-Stage Development

Marrone's (MBII) advancements strengthen its lead position as the supplier of choice for growers looking to meet the high demand for responsibly-grown food and fiber.

1 month ago - Zacks Investment Research

Marrone Bio Prepares to Submit Registration for Next-Generation Crop Protection Product in North America

Company Also Looks to Expand Footprint in South America with Regulatory Submission of Bionematicide Seed Treatment, MBI-206, in Brazil Company Also Looks to Expand Footprint in South America with Regula...

2 months ago - GlobeNewsWire

Marrone (MBII) & Terramera Partner to Boost Crop Protection

Marrone (MBII) and Terramera are collaborating to bring technological and biological know-how to the market to enhance crop protection and create sustainable agricultural technologies.

3 months ago - Zacks Investment Research

Marrone Bio (MBII) Q2 Earnings and Revenues Miss Estimates

Marrone Bio's (MBII) Q2 revenues were affected by severe drought in the western United States that led to reduced demand for insecticides and fungicides.

3 months ago - Zacks Investment Research

Marrone Bio Innovations, Inc. (MBII) Reports Q2 Loss, Lags Revenue Estimates

Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of -100.00% and -28.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the...

3 months ago - Zacks Investment Research

Marrone Bio Innovations: Q2 Earnings Insights

Shares of Marrone Bio Innovations (NASDAQ:MBII) fell 4.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 0.00% year over year to ($0.02), w...

3 months ago - Benzinga

Marrone Bio Innovations, Inc. Reports Second-Quarter 2021 Financial Results

DAVIS, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial...

3 months ago - GlobeNewsWire

Marrone Bio Innovations, Inc. (MBII) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Marrone Bio Innovations, Inc. (MBII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Marrone Bio leading the charge toward more environmentally-conscious effective pest management for farmers

Marrone's products are made from naturally-occurring substances like bacteria or plant extracts Biopesticides used in conjunction with chemical ones gives growers more control over pests The biopesticid...

5 months ago - Proactive Investors

Marrone Bio strikes partnership with ATP Nutrition to distribute Stargus Biofungicide on Canadian broad-acre crops

Marrone Bio Innovations Inc (NASDAQ: MBII) has entered into a partnership with ATP Nutrition of Manitoba to distribute Stargus Biofungicide on Canadian broad-acre crops such as canola, dry beans, peas, ...

5 months ago - Proactive Investors

Marrone Bio Innovations Partners with ATP Nutrition to Distribute Stargus® Biofungicide in Canada

Agreement Marks Expansion into the Broad Acre Crops Market Agreement Marks Expansion into the Broad Acre Crops Market

5 months ago - GlobeNewsWire

Marrone Bio Innovations, Inc. (MBII) Reports Q1 Loss, Misses Revenue Estimates

Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of 0.00% and -0.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the st...

6 months ago - Zacks Investment Research

Marrone Bio sees 1Q revenue grow 14% on improved balance sheet amid strong biological crop protection sales

Marrone Bio Innovations Inc (NASDAQ) reported its 11th consecutive growth quarter with revenues increasing 14% year-over-year to $11 million. The Davis, California-based group attributed the revenue gro...

6 months ago - Proactive Investors

Marrone Bio Innovations Issues Shareholder Letter

DAVIS, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to su...

6 months ago - GlobeNewsWire

Marrone Bio Innovations, Inc. Reports First-Quarter 2021 Financial Results

DAVIS, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) has provided its financial results for the first quarter ended March 31, 2021. Key results include:

6 months ago - GlobeNewsWire

Will Marrone Bio Innovations, Inc. (MBII) Report Negative Earnings Next Week? What You Should Know

Marrone Bio Innovations, Inc. (MBII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research